Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Uyama H, Tomita Y, Nakamura H, Nakamori S, Zhang B, Hoshida Y, Enomoto H, Okuda Y, Sakon M, Aozasa K, Kawase I, Hayashi N, Monden M.
Uyama H, et al. Among authors: zhang b.
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6043-8. doi: 10.1158/1078-0432.CCR-06-1064.
Clin Cancer Res. 2006.
PMID: 17062679